摘要
目的观察孟鲁司特钠对哮喘慢性持续期患儿IL-2、肿瘤坏死因子及肺功能的影响。方法随机选择门诊处于哮喘慢性持续期的患儿52例,随机分为两组,治疗观察1年。观察治疗前后IL-2、肿瘤坏死因子及肺功能的变化。结果孟鲁司特钠组患儿血IL-2升高、肿瘤坏死因子含量降低,各项肺功能指标明显提高,治疗前后比较差异有统计学意义(P<0.05)。结论孟鲁司特钠能降低气道高反应性,增强免疫因子IL-2、降低致炎性肿瘤坏死因子含量,调节Th1/Th2平衡。
Objective: Montelukast sodium is an asthmatic slow duration IL-2,the factor of necrosis and lungs.Methods: random choice clinic is in chronic asthma duration of the 52 cases randomly divided into two groups.the treatment of observation.observation a year before and after treatment IL-2,the factor of necrosis and lungs.Results:Montelukast sodium group blood IL-2 increase,the tumor necrosis factor,lung function in various indicators improved obviously and treatment are differences and there are statistical significance(P 0.05).Conclusion:Montelukast sodium can reduce high response to the press,enhancement immunity factor IL-2、 the colors of the dead level of cytokine factor,adjust Th1/ Th2 balance.
出处
《泰山医学院学报》
CAS
2010年第5期364-367,共4页
Journal of Taishan Medical College